Diagnoplex's Series B - II Round

Diagnoplex raised a round of funding on June 07, 2013.

Diagnoplex is leveraging its molecular platform capabilities to develop a colorectal cancer (CRC) screening test. Diagnoplex's lead product, Colox, is a convenient and minimally-invasive blood test de…

Articles about Diagnoplex's Series B - II Round: